About
Stephen R. Biggar, M.D., Ph.D., has served as an ACADIA director since January 2013 and as Chair of the Board since June 2016. He is a Partner at Baker Bros. Advisors LP, a registered investment adviser focused on long-term investments in life-sciences companies, which he joined in 2000. He currently serves on the boards of Kiniksa Pharmaceuticals and TScan Therapeutics. He received an M.D. and a Ph.D. in immunology from Stanford University and a B.S. in genetics from the University of Rochester.
Roles
Acadia Pharmaceuticals Inc.
Chair of the Board · Current role
January 2013–present
Baker Bros. Advisors LP
Partner
2000 - present
External Roles
Kiniksa Pharmaceuticals, Ltd.
Director
—
TScan Therapeutics, Inc.
Director
—
Notch Therapeutics, Inc.
Director
—
University of Rochester
Trustee
—
Director Compensation
FY 2025Fees earned or paid in cash
$58,445
ComponentAnnual Board and committee cash retainers earned in FY2025
Option awards
$176,392
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Stock awards
$180,705
ComponentAnnual restricted stock unit grant, ASC 718 grant-date fair value
Total
$415,542
Also at Acadia Pharmaceuticals Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.